A pilot study has found evidence of Bartonella and Babesia infection in almost half of 50 blood samples from patients ...
Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. | Quest ...
During the Jan. 28 Alzheimer's Drug Discover Foundation lecture, panelists said the tests will revolutionize diagnosis and ...
ST. LOUIS--(BUSINESS WIRE)--C₂N Diagnostics’ PrecivityAD blood test, used by healthcare providers to determine Alzheimer’s disease (AD) pathology, has the potential to provide significant cost savings ...
Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...
MedPage Today on MSN
Test for Early Pancreatic Cancer Suggests Potential for High-Risk Patients
A panel of four biomarkers had high accuracy for distinguishing cancer from noncancer ...
Swedish researchers discover a blood test that can detect Parkinson's disease up to 20 years before symptoms appear, offering ...
Widely used lung function tests often fail to detect lung disease in Black patients, according to research — and experts are calling for new methods of testing. Spirometry, the most common lung ...
The Food and Drug Administration has greenlit Japan-based test manufacturer Fujirebio to begin marketing its blood test for helping doctors diagnose Alzheimer's disease in some patients, clearing the ...
Of importance is that PAs work as part of a collaborative team. So if a question requires input from a physician or if the test results tie into a broader care plan, PAs will often explain the results ...
Hone Health reports that chronic inflammation is a key factor in heart disease risk often overlooked in standard health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results